Back

CME Outfitters, LLC

  • Adiposity
  • Glucagon-Like Peptide-1 Receptor Agonists
  • Inflammatory Bowel Diseases
  • Janus Kinase Inhibitors
  • Obesity

Beyond the Bowel: Addressing Obesity as a Modifiable Driver of IBD Outcomes

Obesity is transforming the landscape of inflammatory bowel disease (IBD), shaping disease activity, treatment response, and long-term prognosis. As evidence reveals the impact of excess weight on biologic and JAK inhibitor effectiveness, emerging anti-obesity therapies, including GLP-1 receptor agonists, are creating new opportunities to improve patient outcomes. To stay ahead of this rapidly evolving field, gastroenterologists and multidisciplinary care teams need timely, evidence-based education to confidently integrate obesity management into personalized, stigma-free IBD care. In this CME Outfitters AI-powered precision learning activity, expert faculty will help clinicians translate the latest evidence into meaningful improvements in patient care. Learners will explore the immunometabolic mechanisms through which visceral and mesenteric adipose tissue drive IBD disease activity, influence treatment response, and increase surgical risk in people living with IBD and obesity. Through interactive modules, learners will strengthen their ability to systematically assess and characterize adiposity using validated approaches during routine gastroenterology visits, identify individuals at highest risk based on adiposity distribution, and apply these insights to real-world clinical decision-making. Faculty will demonstrate how to build individualized, patient-centered treatment plans that integrate weight management strategies and the safe, evidence

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 1 creditAMA PRA Category 1 Credit™Up to 1 creditNursingUp to 1 credit

MOC types

ABIM — Medical KnowledgeUp to 1 point

FDA REMS

No

Qualifies for MIPS

Yes

Pricing

Free

Reported to ACCME by the provider

  • On-demand / recorded video
  • includes Online course / module
  • Credit · Up to 1 credit
  • MOC · Up to 1 point
  • Commercial Support
  • Released
    Sep 12, 2026
  • Last day to claim credit
    Sep 13, 2027 11 months left